CytoDyn
This securities fraud class action arises out of Defendants’ public conduct and misrepresentations concerning CytoDyn’s only prospective drug, leronlimab, during […]
This securities fraud class action arises out of Defendants’ public conduct and misrepresentations concerning CytoDyn’s only prospective drug, leronlimab, during […]
Case Caption: In re Foundation Building Materials, Inc. Stockholder Litigation, C.A. Case Number: 2022-0466-JTL Court: Court of Chancery of the
The Firm represented and funded a number of institutional investors in securities litigation in Australia against BHP Billiton Limited (now
The Firm represented and funded a number of institutional investors in litigation in Germany against Deutsche Bank AG (“Deutsche Bank”).
The Firm represented and funded a number of institutional investors in a direct action in Paris, France, against Vivendi Universal
The Firm represented and funded a number of institutional investors in securities litigation in Tokyo, Japan, against Mitsubishi Motors Corporation
Case Caption: In re Bucks County Employees’ Retirement System, et al. v. Clayton, Dubilier & Rice, LLC, et al. Case
Case Caption: In re Mylan N.V. Securities Litigation Court: United States District Court for the Western District of Pennsylvania Case Number: 2:20-cv-00955-NR Judge: Honorable